Novartis Pharmaceuticals Canada Inc.
Novartis Pharmaceuticals Canada Inc., a subsidiary of the global healthcare leader Novartis AG, is headquartered in Canada and operates extensively across the country. Founded in 1996, the company has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines and advanced therapies in areas such as oncology, cardiology, and immunology.
With a commitment to research and development, Novartis Canada has introduced several groundbreaking treatments that address unmet medical needs, setting them apart in a competitive market. Their portfolio includes unique biologics and targeted therapies that have significantly improved patient outcomes. Recognised for its contributions to healthcare, Novartis holds a strong market position, consistently ranking among the top pharmaceutical companies in Canada.
+62 vs industry average
Novartis Pharmaceuticals Canada Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novartis Pharmaceuticals Canada Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Novartis Pharmaceuticals Canada Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Novartis Pharmaceuticals Canada Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novartis Pharmaceuticals Canada Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project